Investigating physical activity and cardiovascular risk in breast cancer survivors
The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer
This study is trying to see how different levels of physical activity, like walking or exercising, can affect heart health in women who have survived breast cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 40 Years to 80 Years |
| Sex | Female |
| Sponsor | Hacettepe University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Ankara, State) |
| Trial ID | NCT06837701 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between physical activity levels and cardiovascular risk in patients who have survived breast cancer. It focuses on determining the optimal amount of walking or moderate to vigorous physical activity based on the cardiovascular health status of participants. The study will include women aged 40-80 who are at least 15 months post-surgery and 6 months post-active treatment. By assessing the impact of physical activity on cardiovascular outcomes, the study seeks to provide insights into improving health and quality of life for breast cancer survivors.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 40-80 who are at least 15 months post-breast cancer surgery and 6 months post-active treatment.
Not a fit: Patients with active infections, neurological diseases, or other conditions that may affect exercise performance will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved cardiovascular health and reduced mortality risk for breast cancer survivors through tailored physical activity recommendations.
How similar studies have performed: While there is existing evidence linking physical activity to improved outcomes in breast cancer survivors, this specific focus on cardiovascular risk is less explored, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. To be between the ages of 40-80 years, 2. Volunteering to participate in the research, 3. At least 15 months after breast cancer surgery, 4. 6 months after active breast cancer treatment (ie surgery/chemotherapy) 5. Having no problem in reading and/or understanding the scales and being able to cooperate with the tests. Exclusion Criteria: 1. Presence of active infection, 2. Having a neurological disease or other clinical diagnosis that may affect cognitive status, 3. Having musculoskeletal and neurological disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance. 4. Presence of unstable hypertension or diabetes mellitus
Where this trial is running
Ankara, State
- Hacettepe University — Ankara, State, Turkey (Recruiting)
Study contacts
- Principal investigator: Ebru Calik Kutukcu, PhD — Hacettepe University
- Study coordinator: Ebru Calik Kutukcu, PhD
- Email: ebru.calik@hacettepe.edu.tr
- Phone: 3123051576
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.